About

Dr. Mark A. Rettenmaier is a pioneering gynecologic oncologist whose research has fundamentally advanced the application of minimally invasive and robotic-assisted surgery in the treatment of gynecologic malignancies. His work focuses on improving surgical outcomes and patient survival, particularly for cervical, endometrial, and ovarian cancers. Dr. Rettenmaier’s landmark 2015 study on survival rates in cervical cancer patients (121 citations) provided critical five-year outcome data comparing open, robotic, and laparoscopic radical hysterectomies. He also demonstrated the safety and feasibility of robotic lymph node staging in early-stage ovarian cancer and documented dramatically reduced vaginal cuff dehiscence rates using barbed sutures (45 citations). His research extends to high-risk populations, including a pivotal comparison of surgical approaches in morbidly obese endometrial cancer patients (42 citations). With over 330 total citations, Dr. Rettenmaier’s work has helped establish robotic surgery as a viable, often superior, alternative to traditional open procedures, directly influencing clinical guidelines and improving recovery and survival for thousands of women.

Research Focus

Key Achievements

6
H-Index
8
Papers
330
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Survival rate comparisons amongst cervical cancer patients treated with an open, robotic-assisted or laparoscopic radical hysterectomy: A five year experience
121 citations · 2015
📈 Most Prolific Year: 2015 (3 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Gynecologic Oncology Associates, St. Joseph Hospital, Nancy Yeary Women's Cancer Research Foundation, Cancer Research Foundation

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago